Private Placement Fundraising Through Stock Acquisition Rights and Other Instruments
First written in FY2017-Q2. 30 of 37 entries say "Advanced", first in FY2017-Q3. Latest entry: FY2027-H1.
4 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「The total number of issued shares increased by 4,046,000, and capital stock and capital reserves each increased by ¥242.760 million through a capital increase via the issuance of new shares, with a payment date of 24 August 2026.」
A third-party allotment of new shares was carried out, resulting in the issuance of 4,046,000 shares, increases of ¥242.760 million each in capital stock and capital reserves, and cash inflows of more than ¥485 million from the share issuance. The Sixteenth and Seventeenth Series Stock Acquisition Rights and the Sixth Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights were also issued. - FY2026AdvancedAnnual report
「Net cash provided by financing activities was ¥4,746 million. This was mainly attributable to proceeds from the issuance of convertible bonds with stock acquisition rights and the issuance of shares through the exercise of stock acquisition rights.」
Through the issuance and exercise of the Twelfth, Thirteenth and Fourteenth Series Stock Acquisition Rights and the Fourth Series Bonds with Stock Acquisition Rights, cash provided by financing activities increased by ¥4,746 million. - FY2026-H1AdvancedAnnual report
「The Company issued new shares upon receiving partial exercises of the Twelfth Series Stock Acquisition Rights issued through a third-party allotment. As a result, capital stock and capital reserves each increased by ¥57.302 million」
During the current interim consolidated accounting period, 424,500 shares were issued through the partial exercise of the Twelfth Series Stock Acquisition Rights, and capital stock and capital reserves each increased by ¥57.302 million. In addition, after the filing, approval was granted on 26 September 2025 for the issuance of the Thirteenth and Fourteenth Series Stock Acquisition Rights and the Fourth and Fifth Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights. - FY2025AdvancedAnnual report
「During the fiscal year, cash provided by financing activities increased by ¥531 million. This was mainly attributable to proceeds from the issuance of shares upon the exercise of stock acquisition rights.」
Annual proceeds from the issuance of shares through the exercise of stock acquisition rights amounted to ¥531 million, and financing continued to be carried out. - FY2025-H1AdvancedAnnual report
「1 March 2024 to 31 August 2024 30,356,762 44,893,293 173,640 3,442,245 173,640 2,458,445 (Note) 2. The increase resulted from the exercise of stock acquisition rights.」
During the current interim consolidated accounting period, 30,356,762 shares were issued through the exercise of stock acquisition rights, and capital stock and capital reserves each increased by ¥173.640 million. The impact of the stock split is also included. - FY2025-Q1AdvancedAnnual report
「The Company received partial exercises of the Tenth Series Stock Acquisition Rights on 2 April 2024 and the Twelfth Series Stock Acquisition Rights issued through a third-party allotment on 10 May 2024, and issued new shares. As a result, during the cumulative first quarter, capital stock and capital reserves each increased by ¥54.014 million. At the end of the first quarter, capital stock was ¥3,322.619 million and capital surplus was ¥2,905.433 million.」
New shares were issued through partial exercises of the Tenth and Twelfth Series Stock Acquisition Rights, increasing capital stock and capital reserves by ¥54.014 million each during the quarter. - FY2024AdvancedAnnual report
「1 March 2023 to 29 February 2024 999,400 14,536,531 314,032 3,268,604 314,032 2,284,804 (Note) 1. The increases resulted from the exercise of stock acquisition rights.」
During the fiscal year, 999,400 shares were issued through the exercise of stock acquisition rights, and capital stock and capital reserves each increased by ¥314.032 million. Cash provided by financing activities also amounted to ¥681.454 million. - FY2024-Q3AdvancedAnnual report
「1 September 2023 to 30 November 2023 865,400 14,536,531 272,029 3,268,604 272,029 2,284,804 (Note) The increases resulted from the exercise of stock acquisition rights.」
During the current third quarter, 865,400 shares were issued through the exercise of stock acquisition rights, and capital stock and capital reserves each increased by ¥272.029 million. - FY2024-Q2AdvancedAnnual report
「Twelfth Series Stock Acquisition Rights Number of stock acquisition rights (units)* 65,600 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 6,560,000 Exercise period of the stock acquisition rights* 14 August 2023 to 13 August 2026」
The Twelfth Series Stock Acquisition Rights were issued, resulting in 6,560,000 potential shares and an exercise period from 14 August 2023 to 13 August 2026. Proceeds of ¥65.140 million from the issuance of stock acquisition rights were also recorded. - FY2024-Q1AdvancedAnnual report
「1 March 2023 to 31 May 2023 129,000 13,666,131 40,549 2,995,121 40,549 2,011,321 (Note) 1. The increases resulted from the exercise of stock acquisition rights.」
During the current quarter, 129,000 shares were issued through the exercise of stock acquisition rights, and capital stock and capital reserves each increased by ¥40.549 million. - FY2023AdvancedAnnual report
「Cash provided by financing activities during the fiscal year was ¥583 million. This was attributable to proceeds from the issuance of shares upon the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 1,840,900 shares and increased capital stock and capital reserves by ¥295.890 million each. Cash provided by financing activities was ¥583 million. - FY2023-Q3RestatedAnnual report
「1 September 2022 to 30 November 2022 670,000 13,402,631 99,578 2,912,293 99,578 1,928,493 (Note) The increases resulted from the exercise of stock acquisition rights.」
The issuance of 670,000 shares through the exercise of the Ninth Series Stock Acquisition Rights and the ¥99.578 million increase in each of capital stock and capital reserves were also confirmed in the movement table for the current quarter as information identified after the second-quarter filing. - FY2023-Q2AdvancedAnnual report
「On 29 August 2022, the Company received the exercise of the Ninth Series Stock Acquisition Rights from First Link Inc Limited and Liu Yang, respectively, and issued new shares. As a result, during the cumulative second quarter, capital stock and capital reserves each increased by ¥154.034 million」
The Ninth Series Stock Acquisition Rights were exercised, increasing capital stock and capital reserves by ¥154.034 million each. In addition, on 1 September after the filing, each increased by ¥99.578 million through the exercise of rights by Liu Yang. - FY2022AdvancedAnnual report
「Issuance of new shares (exercise of share acquisition rights)」
Through the exercise of the Third Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights and the Eighth Series Stock Acquisition Rights, 883,870 shares were issued during the fiscal year, and cash provided by financing activities increased by ¥195.152 million. - FY2022-Q3AdvancedAnnual report
「In addition, on 19 November of the same year, the Company received the exercise of the Eighth Series Stock Acquisition Rights from Kingdom Capital Resources Ltd and issued new shares, increasing capital stock and capital reserves by ¥98.968 million each.」
Through the exercise of the Eighth Series Stock Acquisition Rights, 400,000 shares were issued on 19 November 2021, and capital stock and capital reserves each increased by ¥98.968 million. - FY2022-Q2RestatedAnnual report
「On 1 March 2021, the Company received the exercise of the Third Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights from Zhou DiSun, and on 12 April of the same year from Cheung Yuk Shan Shirley (張玉珊), respectively, and converted the bonds into new shares. As a result, during the cumulative first quarter, capital stock and capital reserves each increased by ¥150 million」
The exercise of the Third Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights and the ¥150 million increase in each of capital stock and capital reserves were reconfirmed in the notes for the cumulative second quarter. - FY2022-Q1AdvancedAnnual report
「On 1 March 2021, the Company received the exercise of the Third Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights from Zhou DiSun (周迪荪), and on 12 April of the same year from Cheung Yuk Shan Shirley (張玉珊), respectively, and converted the bonds into new shares. As a result, during the cumulative first quarter, capital stock and capital reserves each increased by ¥150 million」
The Third Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights were exercised, increasing the total number of issued shares by 483,870 and capital stock and capital reserves by ¥150 million each. - FY2021AdvancedAnnual report
「Between 1 March 2021 and 30 April 2021, the total number of issued shares increased by 483,870 shares, while capital stock and capital reserves increased by ¥150 million each through the exercise of stock acquisition rights.」
The Third Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights were exercised by the filing date, resulting in increases of 483,870 shares, ¥150 million in capital stock and ¥150 million in capital reserves. - FY2021-Q3AdvancedAnnual report
「Eleventh Series Stock Acquisition Rights Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 1,128,900 shares Exercise period of the stock acquisition rights* 11 November 2020 to 10 November 2023 Third Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 483,870 Balance of bonds with stock acquisition rights (¥ million)* 300」
The Eleventh Series Stock Acquisition Rights and Third Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights were issued, with 1,612,770 potential shares and ¥300 million of convertible bonds outstanding disclosed. - FY2020RestatedAnnual report
「Cash provided by financing activities was ¥802 million. This was mainly attributable to proceeds from the issuance of shares upon the exercise of stock acquisition rights.」
The exercise of stock acquisition rights generated ¥802 million of cash provided by financing activities for the full year. The new issuance itself had already been disclosed by the previous quarter. - FY2020-Q3AdvancedAnnual report
「During the cumulative third quarter, capital stock and capital reserves each increased by ¥400 million as a result of the exercise of stock acquisition rights attached to convertible bond-type bonds with stock acquisition rights.」
The stock acquisition rights attached to convertible bond-type bonds were exercised, increasing the total number of issued shares by 2,730,374 during the cumulative third quarter and increasing capital stock and capital reserves by ¥400 million each. - FY2020-Q2AdvancedAnnual report
「At a meeting of the board of directors held on 17 September 2019, the company resolved to issue the Ninth Series stock acquisition rights (the "stock acquisition rights") and the Second Series unsecured convertible bonds with stock acquisition rights (the "convertible bonds"). On 3 October 2019, payment was completed for the issue prices of the stock acquisition rights and convertible bonds, ¥7,252,200 and ¥800,000,000, respectively, totaling ¥807,252,200.」
The issuance of the Ninth Series Stock Acquisition Rights and the Second Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights was approved, and payment totaling ¥807,252,200 was completed on 3 October 2019. New financing through a third-party allotment is moving into the execution stage. - FY2019AdvancedAnnual report
「Cash provided by financing activities increased by ¥855 million (compared with a decrease of ¥11 million in the same period of the previous year). This was mainly due to expenditures for the repayment of long-term borrowings and the issuance of shares through the exercise of stock acquisition rights.」
Cash flow from financing activities for the full year increased by ¥855 million, mainly due to the issuance of shares through the exercise of stock acquisition rights and other factors. - FY2019-Q3AdvancedAnnual report
「The company raised funds on 3 December 2018, 20 December 2018 and 7 January 2019 through the partial exercise of the Eighth Series stock acquisition rights issued to KINGDOM CAPITAL RESOURCES LIMITED on 5 November 2018.」
Financing was completed through the partial exercise of the Eighth Series stock acquisition rights, with the disclosure of 1,000,000 common shares, total exercise proceeds of ¥488 million, and increases of ¥247.42 million each in capital stock and the capital reserve. - FY2019-Q2RestatedAnnual report
「The company received exercise notices for stock acquisition rights and payment for new shares from KINGDOM CAPITAL RESOURCES LIMITED on 27 March 2018 and from 遠南企業股分有限公司 on 9 May 2018. As a result, during the cumulative period of the second quarter of the current consolidated fiscal year, capital stock and the capital reserve each increased by ¥278 million. At the end of the second quarter of the current consolidated fiscal year, capital stock was ¥1,762 million and capital surplus was ¥1,354 million.」
The fact that capital stock and the capital reserve each increased by ¥278 million through the exercise and payment for stock acquisition rights has been reaffirmed. This does not indicate progress in a new share issuance, but is a continuation of the disclosure of previously disclosed financing results. - FY2019-Q1AdvancedAnnual report
「The company received exercise notices for stock acquisition rights and payment for new shares from KINGDOM CAPITAL RESOURCES LIMITED on 27 March 2018 and from 遠南企業股分有限公司 on 9 May 2018. As a result, during the cumulative period of the first quarter of the current consolidated fiscal year, capital stock and the capital reserve each increased by ¥278 million. At the end of the first quarter of the current consolidated fiscal year, capital stock was ¥1,762 million and capital surplus was ¥1,354 million.」
The exercise of stock acquisition rights was completed, increasing the total number of shares issued by 820,000 and increasing capital stock and the capital reserve by ¥278 million each. - FY2018AdvancedAnnual report
「Total number of these stock acquisition rights: 14,826; potential shares issued: 1,482,600; proceeds from financing: ¥2,027,025,546; exercise period: 22 March 2018 to 19 March 2021.」
The issuance and payment for the Seventh Series stock acquisition rights were completed, with disclosed proceeds of approximately ¥2 billion and 1,482,600 potential shares. - FY2018-Q3AdvancedAnnual report
「During the nine-month period of the current consolidated fiscal year, the Fifth and Sixth Series stock acquisition rights were exercised. As a result, the total number of shares issued increased by 1,000,000, while capital stock and the capital reserve each increased by ¥141.394 million.」
The exercise of the Fifth and Sixth Series stock acquisition rights was completed during the cumulative period, resulting in 1,000,000 additional shares issued and increases of ¥141.394 million each in capital stock and the capital reserve. - FY2018-Q2AdvancedAnnual report
「The Sixth Series stock acquisition rights were exercised on 1 August 2017, 30 August 2017 and 31 August 2017. As a result, capital stock and the capital reserve each increased by ¥113.911 million.」
The Sixth Series stock acquisition rights were exercised in August, increasing the total number of shares issued by 800,000 and increasing capital stock and the capital reserve by ¥113.911 million each. - FY2017AdvancedAnnual report
「Following conversion requests for the convertible bonds with stock acquisition rights (the "bonds"), the bonds decreased by ¥400 million, while capital stock and capital surplus each increased by ¥200 million.」
Conversion requests for the issued convertible bonds with stock acquisition rights were completed, resulting in a ¥400 million decrease in bonds and increases in capital stock and capital surplus. - FY2017-Q3AdvancedAnnual report
「On 28 October 2016, the total number of shares issued increased by 1,423,487 through the exercise of stock acquisition rights attached to convertible bonds, while capital stock and the capital reserve each increased by ¥200 million.」
The exercise of the convertible bonds with stock acquisition rights issued as part of the financing resolved and issued in the previous quarter was completed, resulting in increases in shares, capital stock and the capital reserve. - FY2017-Q2First statedAnnual report
「Issuance of the sixth series of stock acquisition rights and the first series of unsecured convertible bonds with stock acquisition rights through a private placement」
The company resolved to issue stock acquisition rights covering 800,000 shares as the fifth series, as well as 60 sixth-series rights representing 1,200,000 potential shares and raising ¥343,059,600, and 40 first-series unsecured convertible bonds with stock acquisition rights representing 1,423,487 potential shares and raising ¥400,000,000. The exercise price for the sixth-series rights and the conversion price were ¥281 per share, and the payment date was set for 27 October 2016.